Malaria during Pregnancy (Q36284603)

13 August 2017

Malaria during Pregnancy (English)

1 reference

pregnancy-associated malaria

13 August 2017

0 references

0 references

1 reference

2

Patrick E Duffy

1 reference

13 August 2017

Michal Fried

1

1 reference

13 August 2017

17 February 2017

1 reference

Cold Spring Harbor Perspectives in Medicine

13 August 2017

1 reference

13 August 2017

7

1 reference

13 August 2017

6

1 reference

Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated beta chemokine expression.

13 August 2017

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Characterization of proteoglycans of human placenta and identification of unique chondroitin sulfate proteoglycans of the intervillous spaces that mediate the adherence of Plasmodium falciparum-infected erythrocytes to the placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Antibodies to chondroitin sulfate A-binding infected erythrocytes: dynamics and protection during pregnancy in women receiving intermittent preventive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Structural requirements for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate proteoglycans of human placenta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Inhibition of chondroitin-4-sulfate-specific adhesion of Plasmodium falciparum-infected erythrocytes by sulfated polysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Intermittent preventive therapy with sulfadoxine-pyrimethamine for malaria in pregnancy: a cross-sectional study from Tororo, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Using an improved phagocytosis assay to evaluate the effect of HIV on specific antibodies to pregnancy-associated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Antibodies that induce phagocytosis of malaria infected erythrocytes: effect of HIV infection and correlation with clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

The risk of malaria in Ghanaian infants born to women managed in pregnancy with intermittent screening and treatment for malaria or intermittent preventive treatment with sulfadoxine/pyrimethamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Clinical malaria in African pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Differential recognition of P. falciparum VAR2CSA domains by naturally acquired antibodies in pregnant women from a malaria endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Levels of macrophage inflammatory protein 1 alpha (MIP-1 alpha) and MIP-1 beta in intervillous blood plasma samples from women with placental malaria and human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso).

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Parity-dependent recognition of DBL1X-3X suggests an important role of the VAR2CSA high-affinity CSA-binding region in the development of the humoral response against placental malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an op

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

CXC ligand 9 response to malaria during pregnancy is associated with low-birth-weight deliveries

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Pregnancy malaria: cryptic disease, apparent solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Placental malaria induces variant-specific antibodies of the cytophilic subtypes immunoglobulin G1 (IgG1) and IgG3 that correlate with adhesion inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed nets

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Malaria cellular immune responses in neonates from Cameroon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Acquisition of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Maternal antibodies block malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Plasmodium falciparum: chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Diagnosing malaria in pregnancy: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Drugs for preventing malaria in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Insight into antigenic diversity of VAR2CSA-DBL5ε domain from multiple Plasmodium falciparum placental isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Parasite burden and severity of malaria in Tanzanian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Malaria chemoprophylaxis, birth weight and child survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Placental pathology in malaria: a histological, immunohistochemical, and quantitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Relationship between human immunodeficiency virus type 1 coinfection, anemia, and levels and function of antibodies to variant surface antigens in pregnancy-associated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Fetal responses during placental malaria modify the risk of low birth weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Cytokine profiles at birth predict malaria severity during infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Antigen persistence of rapid diagnostic tests in pregnant women in Nanoro, Burkina Faso, and the implications for the diagnosis of malaria in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Distinct Th1- and Th2-Type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Evaluation of the OptiMAL rapid antigen test and species-specific PCR to detect placental Plasmodium falciparum infection at delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Cytoadherence of Plasmodium falciparum-infected erythrocytes in the human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Parity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

How hidden can malaria be in pregnant women? Diagnosis by microscopy, placental histology, polymerase chain reaction and detection of histidine-rich protein 2 in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Improved pregnancy outcomes in women exposed to malaria with high antibody levels against Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Changing Trends in P. falciparum Burden, Immunity, and Disease in Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Haemozoin as a marker of placental parasitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Effects of pregnancy and intensity of Plasmodium falciparum transmission on immunoglobulin G subclass responses to variant surface antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Diagnosis of placental malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Markers of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in placenta and circulation of pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Genome-wide expression analysis of placental malaria reveals features of lymphoid neogenesis during chronic infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

A novel histological grading scheme for placental malaria applied in areas of high and low malaria transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Chondroitin sulfate proteoglycan but not hyaluronic acid is the receptor for the adherence of Plasmodium falciparum-infected erythrocytes in human placenta, and infected red blood cell adherence up-regulates the receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Efficacy of malaria prevention during pregnancy in an area of low and unstable transmission: an individually-randomised placebo-controlled trial using intermittent preventive treatment and insecticide-treated nets in the Kabale Highlands, southweste

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Intermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: a counter perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Malaria during pregnancy in an area of unstable endemicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Effects of sex, parity, and sequence variation on seroreactivity to candidate pregnancy malaria vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Massive chronic intervillositis of the placenta associated with malaria infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Maternal anemia and risk of adverse birth and health outcomes in low- and middle-income countries: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Evidence for the involvement of VAR2CSA in pregnancy-associated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Placental malaria increases malaria risk in the first 30 months of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Changes in the Levels of Chemokines and Cytokines in the Placentas of Women withPlasmodium falciparumMalaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Performance of the OptiMAL dipstick in the diagnosis of malaria infection in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Four Artemisinin-Based Treatments in African Pregnant Women with Malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Persistent ICT malaria P.f/P.v panmalarial and HRP2 antigen reactivity after treatment of Plasmodium falciparum malaria is associated with gametocytemia and results in false-positive diagnoses of Plasmodium vivax in convalescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Malaria risk factors in women on intermittent preventive treatment at delivery and their effects on pregnancy outcome in Sanaga-Maritime, Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Factors associated with postpartum hemorrhage maternal death in referral hospitals in Senegal and Mali: a cross-sectional epidemiological survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Variable adhesion abilities and overlapping antigenic properties in placental Plasmodium falciparum isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

High level of var2csa transcription by Plasmodium falciparum isolated from the placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

High avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Accuracy of an HRP-2/panLDH rapid diagnostic test to detect peripheral and placental Plasmodium falciparum infection in Papua New Guinean women with anaemia or suspected malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Comparison of the OptiMAL rapid test and microscopy for detection of malaria in pregnant women in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Placental malaria and the relationship to pregnancy outcome at Gushegu District Hospital, Northern Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

The Performance of a Rapid Diagnostic Test in Detecting Malaria Infection in Pregnant Women and the Impact of Missed Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Non-falciparum malaria infections in pregnant women in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Comparison of a rapid field immunochromatographic test to expert microscopy for the detection of Plasmodium falciparum asexual parasitemia in Thailand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1101%2FCSHPERSPECT.A025551

Detection of the Plasmodium falciparum antigen histidine-rich protein 2 in blood of pregnant women: implications for diagnosing placental malaria

21 January 2018

1 reference

12 December 2020

Development of antibodies against chondroitin sulfate A-adherent Plasmodium falciparum in pregnant women

1 reference

12 December 2020

Plasmodium falciparum: adhesion of placental isolates modulated by the sulfation characteristics of the glycosaminoglycan receptor

1 reference

12 December 2020

Malaria-associated cytokine changes in the placenta of women with pre-term deliveries in Yaounde, Cameroon.

1 reference

12 December 2020

Evaluation of a malaria rapid diagnostic test for assessing the burden of malaria during pregnancy.

1 reference

12 December 2020

Community-based promotional campaign to improve uptake of intermittent preventive antimalarial treatment in pregnancy in Burkina Faso.

1 reference

12 December 2020

Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment

1 reference

12 December 2020

Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation

1 reference

12 December 2020

An analysis of malaria in pregnancy in Africa

1 reference

12 December 2020

Epidemiology, malaria and pregnancy

1 reference

12 December 2020

The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi.

1 reference

12 December 2020

Malaria chemoprophylaxis, infection of the placenta and birth weight in Gambian primigravidae.

1 reference

12 December 2020

Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes

1 reference

12 December 2020

Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.

1 reference

12 December 2020

10.1101/CSHPERSPECT.A025551

Identifiers

DOI

1 reference

13 August 2017

0 references

1 reference

PubMed ID

28213434